107 related articles for article (PubMed ID: 12821945)
21. Regulation and mechanisms of mammalian double-strand break repair.
Valerie K; Povirk LF
Oncogene; 2003 Sep; 22(37):5792-812. PubMed ID: 12947387
[TBL] [Abstract][Full Text] [Related]
22. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Rad51 inhibits double-strand break-induced homologous recombination but does not affect gene conversion tract lengths.
Paffett KS; Clikeman JA; Palmer S; Nickoloff JA
DNA Repair (Amst); 2005 Jun; 4(6):687-98. PubMed ID: 15878310
[TBL] [Abstract][Full Text] [Related]
24. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycle-dependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells.
Frankenberg-Schwager M; Becker M; Garg I; Pralle E; Wolf H; Frankenberg D
Radiat Res; 2008 Dec; 170(6):784-93. PubMed ID: 19138034
[TBL] [Abstract][Full Text] [Related]
25. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.
Qian H; Wang T; Naumovski L; Lopez CD; Brachmann RK
Oncogene; 2002 Nov; 21(51):7901-11. PubMed ID: 12420228
[TBL] [Abstract][Full Text] [Related]
26. Human transcriptional coactivator PC4 stimulates DNA end joining and activates DSB repair activity.
Batta K; Yokokawa M; Takeyasu K; Kundu TK
J Mol Biol; 2009 Jan; 385(3):788-99. PubMed ID: 19038270
[TBL] [Abstract][Full Text] [Related]
27. [Direct role of p53 on homologous recombination].
Saintigny Y; Bertrand P; Lopez BS
Med Sci (Paris); 2005 Jan; 21(1):43-8. PubMed ID: 15639019
[TBL] [Abstract][Full Text] [Related]
28. The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.
Ma B; Pan Y; Gunasekaran K; Keskin O; Venkataraghavan RB; Levine AJ; Nussinov R
Phys Biol; 2005 Jun; 2(2):S56-66. PubMed ID: 16204849
[TBL] [Abstract][Full Text] [Related]
29. Nonhomologous end-joining of site-specific but not of radiation-induced DNA double-strand breaks is reduced in the presence of wild-type p53.
Dahm-Daphi J; Hubbe P; Horvath F; El-Awady RA; Bouffard KE; Powell SN; Willers H
Oncogene; 2005 Mar; 24(10):1663-72. PubMed ID: 15688024
[TBL] [Abstract][Full Text] [Related]
30. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
31. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
Schavolt KL; Pietenpol JA
Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY
Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976
[TBL] [Abstract][Full Text] [Related]
33. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation.
Kim SB; Chae GW; Lee J; Park J; Tak H; Chung JH; Park TG; Ahn JK; Joe CO
Cell Death Differ; 2007 May; 14(5):982-91. PubMed ID: 17186020
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
Willis A; Jung EJ; Wakefield T; Chen X
Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
[TBL] [Abstract][Full Text] [Related]
35. Relative contribution of homologous recombination and non-homologous end-joining to DNA double-strand break repair after oxidative stress in Saccharomyces cerevisiae.
Letavayová L; Marková E; Hermanská K; Vlcková V; Vlasáková D; Chovanec M; Brozmanová J
DNA Repair (Amst); 2006 May; 5(5):602-10. PubMed ID: 16515894
[TBL] [Abstract][Full Text] [Related]
36. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.
Kakudo Y; Shibata H; Otsuka K; Kato S; Ishioka C
Cancer Res; 2005 Mar; 65(6):2108-14. PubMed ID: 15781620
[TBL] [Abstract][Full Text] [Related]
37. The interaction of p53 with replication protein A mediates suppression of homologous recombination.
Romanova LY; Willers H; Blagosklonny MV; Powell SN
Oncogene; 2004 Dec; 23(56):9025-33. PubMed ID: 15489903
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.
Bullock AN; Henckel J; Fersht AR
Oncogene; 2000 Mar; 19(10):1245-56. PubMed ID: 10713666
[TBL] [Abstract][Full Text] [Related]
39. The DNA binding regulatory domain of p53: see the C.
Wolkowicz R; Rotter V
Pathol Biol (Paris); 1997 Dec; 45(10):785-96. PubMed ID: 9769942
[TBL] [Abstract][Full Text] [Related]
40. Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutant.
Lassus P; Bertrand C; Zugasti O; Chambon JP; Soussi T; Mathieu-Mahul D; Hibner U
Oncogene; 1999 Aug; 18(33):4699-709. PubMed ID: 10467417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
